Table 1.
Patients groups characteristics
| No platinum reduction or delays | Platinum reduction only | Delays only | Both Platinum reduction and delays | |
|---|---|---|---|---|
| (N = 15) | (N = 11) | (N = 12) | (N = 44) | |
| Age, mean (range) | 46.6 (22–67) | 52.0 (42–65) | 60.8 (42–82) | 59.7 (40–82) |
| BMI, mean (range) | 24.9 (16.1–46.1) | 25.1 (18.2–33.7) | 26.5 (19.5–39.5) | 26.9 (16.7–38.2) |
| (kg/m2) | ||||
| Histology | ||||
| Serous | 13 (86.6%) | 11 (100%) | 10 (83.4%) | 32 (72.7%) |
| Mucinous | 1 (6.7%) | 0 (0%) | 1 (8.3%) | 4 (9.1%) |
| Endometrioid | 0 (0%) | 0 (0%) | 1 (8.3%) | 1 (2.3%) |
| Clear cell | 0 (0%) | 0 (0%) | 0 (0%) | 2 (4.5%) |
| Mixed | 1 (6.7%) | 0 (0%) | 0 (0%) | 5 (11.4) |
| Tumor grade | ||||
| Grade 1 | 0 (0%) | 1 (9.1%) | 1 (8.3%) | 6 (13.6%) |
| Grade 2 | 11 (73.3%) | 8 (72.7%) | 9 (75.0%) | 24 (54.6%) |
| Grade 3 | 4 (26.7%) | 2 (18.2%) | 2 (16.7%) | 14 (31.8%) |
(N = 82).